NL-OMON28644尚未招募不适用
ong-term treatment for cancer patients with deep venous thrombosis or pulmonary embolism: an international registry
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with cancer (excluding non-melanoma skin cancer)
- •Confirmed diagnosis of acute pulmonary embolism or deep venous thrombosis
排除标准
- •legal age limitations
研究者
相似试验
进行中（未招募）
不适用
ong-term treatment for cancer patients with deep vein thrombosis or pulmonary embolism - a randomized open label studyEUCTR2009-015336-15-DEDepartment of Vascular Medicine of the Academic Medical Center1,000
进行中（未招募）
不适用
ong-term treatment for cancer patients with deep vein thrombosis or pulmonary embolism - a randomized open label studyDeep venous thrombosis or pulmonary embolism in patients with cancerMedDRA version: 12.0Level: LLTClassification code 10066899Term: Venous thromboembolismEUCTR2009-015336-15-NLDepartment of Vascular Medicine of the Academic Medical Center1,000
进行中（未招募）
不适用
ong-term treatment for cancer patients with deep venous thrombosis or pulmonary embolism - NDVenous thromboembolism including deep vein thrombosis and pulmonary embolismMedDRA version: 9.1Level: HLTClassification code 10037379MedDRA version: 9.1Level: PTClassification code 10051055EUCTR2009-015336-15-ITIVERSITA` DEGLI STUDI G. D`ANNUNZIO CHIETI1,000
进行中（未招募）
1 期
ong-term treatment of cancer associated VTE: reduced vs full dose of apixaban : API-CAT STUDY for APIxaban Cancer Associated ThrombosisPatients with breast, prostate, and colorectal active cancer, with objectively documented index event of symptomatic or incidental proximal DVT or symptomatic or incidental PE, after 6 months of anticoagulant therapy for the treatment of the index event, with no objectively documented symptomatic recurrence of VTE between the index event and randomization.MedDRA version: 20.0Level: LLTClassification code 10076654Term: Cancer-associated thrombosisSystem Organ Class: 100000004864EUCTR2017-003342-25-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,722
进行中（未招募）
1 期
ong-term treatment of cancer associated VTE: reduced vs full dose of apixaban : API-CAT STUDY for APIxaban Cancer Associated ThrombosisAny cancer diagnosed histologically (other than basal-cell or squamous-cell carcinoma of the skin, primary brain tumor or intra-cerebral metastasis, with objectively documented index event of symptomatic or incidental proximal DVT or symptomatic or incidental PE, afterat least 6 months of anticoagulant therapy for the treatment of the index event, with no objectively documented symptomatic recurrence of VTE between the index event and randomization.MedDRA version: 21.1Level: LLTClassification code 10076654Term: Cancer-associated thrombosisSystem Organ Class: 100000004864EUCTR2017-003342-25-GRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,722